THE APPLICATION OF MELATONIN FOR THE TREATMENT OF PATIENTS WITH MEDICAMENT ADDICTION

摘要

The invention relates to the application of melatonin for the prevention and treatment of patients suffering from addiction, resistance or dependence on benzodiazepine medicamentous forms when excessively used and to a pharmaceutical composition designed for such treatment. The daily adminstration dose ranges from 0.01 to 100 mg. In case of the protection of a patient accepting benzodiazepine medicament the daily melatonin quantity should be under 10 mg. 8 claims